ResearchSite 

 
Print Friendly Version Help and Support
  Research Home

TVO Available Technology Abstracts

Directions: Click the icon above to create a version for printing.




Monoclonal antibodies against mouse LY108 (clones 13G3-19D and 330-AJ) (BIDMC 1314)

Category:    Research Reagents

KeyWords:  Antibody;  Inflammation;  

BIDMC ID:    1314

Abstract:

Mouse IgG2a antibodies that work well for flow cytometry, immunoprecipitation, western blotting applications and in vitro activation of proliferation and cytokine production. Both clones co-stimulate T cells in a similar fashion but clone 330-AJ has better affinity.

Inventor:   Cox Terhorst, Ph.D.

Commercial Opportunity:


Competitive Advantages:


Related Publications:

Fraser CC et al Immunogenetics. 2002 Feb;53(10-11):843-50.
Howie D. et al J Immunol. 2005 May 15;174(10):5931-5.

State of Development:


Related Technology URL:

http://research.bidmc.harvard.edu/research/ResearchPIInfo.ASP?Submit=Display&PersonID=691

Patent Status:

not filed

TVO Contact Info:
     Jodi E Hecht
     Licensing Associate
     jehecht@bidmc.harvard.edu
     Phone: 617-667-4197   Fax: 617-667-0646

     Beth Israel Deaconess Medical Center
     Technology Ventures Office  Room: BR-0200
     330 Brookline Avenue
     Boston, MA 02215



 

Copyright 2009 Beth Israel Deaconess Medical Center | Contact Research Webmaster

IP Address: 38.107.191.80   |  Web Server: research.bidmc.harvard.edu   |  Database Server: Colorado\SQL17   |  App Path: /tvo/tvotech.asp   |  Version:

Browser: CCBot/1.0 (+http://www.commoncrawl.org/bot.html)
SecurityGroup: